Drug Shortage Report for AMIODARONE HYDROCHLORIDE INJECTION

Last updated on 2020-08-06 History
Report ID 119581
Drug Identification Number 02245248
Brand name AMIODARONE HYDROCHLORIDE INJECTION
Common or Proper name Amiodarone Hydrochloride for Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) AMIODARONE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50 mg/mL, MD Vial 3 mL
ATC code C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-07-13
Actual start date
Estimated end date 2020-08-21
Actual end date 2020-08-05
Shortage status Resolved
Updated date 2020-08-06
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Amiodarone Hydrochloride for Injection, 50 mg/mL, MD Vial 3 mL are now available at all distribution centres effective today, August 5, 2020. Please note that this product will remain on allocation. Contract customers will receive 100% of their historical monthly average volumes.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-08-06 English Compare
v5 2020-08-05 French Compare
v4 2020-08-05 English Compare
v3 2020-07-14 English Compare
v2 2020-07-06 French Compare
v1 2020-07-06 English Compare